Blaise Coleman

Blaise A Coleman is currently Chairman at Par Pharmaceutical, Inc., Generics International (US), Inc., Par Pharmaceutical Holdings, Inc., Innoteq, Inc., and Par Pharmaceutical Cos., Inc. (New York).
The current roles also include Independent Director at Ocugen, Inc. starting in 2025, and Director positions at Auxilium Pharmaceuticals LLC, Vintage Pharmaceuticals LLC, Par Sterile Products LLC, Slate Pharmaceuticals LLC, and Endo Innovation Valera LLC.
Former roles include Chairman, President & Chief Executive Officer at BioSpecifics Technologies Corp., President, Chief Executive Officer & Director at Endo LP, and President, Chief Executive Officer & Director at Endo International Plc from 2015 to 2024.
Other former positions include Senior Director-Commercial Finance at AstraZeneca US Investments Ltd. and Chief Financial Officer at AstraZeneca AB from 2013 to 2015.
Education includes undergraduate studies at Widener University and an MBA from The Fuqua School of Business.